2020
DOI: 10.1038/s41598-020-58938-z
|View full text |Cite
|
Sign up to set email alerts
|

Endovascular procedures cause transient endothelial injury but do not disrupt mature neointima in Drug Eluting Stents

Abstract: Extensive application of coronary intravascular procedures has led to the increased need of understanding the injury inflicted to the coronary arterial wall. We aimed to investigate acute and prolonged coronary endothelial injury as a result of guidewire use, repeated intravascular imaging and stenting. These interventions were performed in swine (N = 37) and injury was assessed per coronary segment (n = 81) using an Evans Blue dye-exclusion-test. Scanning electron microscopy and light microscopy were then use… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
32
2

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(34 citation statements)
references
References 22 publications
0
32
2
Order By: Relevance
“…In the propensity-score-matched cohort, no significant difference in sICH risk was observed between patients who were on prior antiplatelet therapy and those not on prior antiplatelet therapy (74/937 [7.9%] vs. 27/477 [5.6%]; aOR 1.47, 95% CI 0.86-2.49; Table 2). Also, no associations were found between prior antiplatelet therapy and functional outcome (median mRS 4 [IQR: 2-6] vs. 4 [2][3][4][5][6]; acOR 0.87, 95% CI 0.65-1.16; Figure 2), successful reperfusion (aOR 1.23, 95% CI 0.77-1.97), mortality (aOR 1.15, 95% CI 0.86-1.54), or the other secondary outcomes. In the sensitivity analysis, in the full cohort (without propensity-score matching), we found neither a difference in sICH risk (aOR 1.48, 95% CI 0.99-2.20) nor a difference in functional outcome (acOR 0.92, 95% CI 0.76-1.10; Figure 2) between groups.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…In the propensity-score-matched cohort, no significant difference in sICH risk was observed between patients who were on prior antiplatelet therapy and those not on prior antiplatelet therapy (74/937 [7.9%] vs. 27/477 [5.6%]; aOR 1.47, 95% CI 0.86-2.49; Table 2). Also, no associations were found between prior antiplatelet therapy and functional outcome (median mRS 4 [IQR: 2-6] vs. 4 [2][3][4][5][6]; acOR 0.87, 95% CI 0.65-1.16; Figure 2), successful reperfusion (aOR 1.23, 95% CI 0.77-1.97), mortality (aOR 1.15, 95% CI 0.86-1.54), or the other secondary outcomes. In the sensitivity analysis, in the full cohort (without propensity-score matching), we found neither a difference in sICH risk (aOR 1.48, 95% CI 0.99-2.20) nor a difference in functional outcome (acOR 0.92, 95% CI 0.76-1.10; Figure 2) between groups.…”
Section: Discussionmentioning
confidence: 99%
“…The formation of microthrombi might be promoted by vessel wall damage caused by EVT. 2 , 3 Use of antiplatelet drugs could potentially reduce periprocedural formation of microthrombi by inhibiting platelet aggregation and inflammation of the vessel wall, which could ultimately improve microvascular reperfusion. 3 On the other hand, one randomized trial showed that antiplatelet therapy increases the risk of symptomatic intracranial hemorrhage (sICH) when administered early—within 90 min—after intravenous treatment with alteplase.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Stent deployment induces significant injury to the vascular wall at the site of implantation including denudation of the vascular endothelium. 7,12 Considering the role that normal, functioning endothelial cells (ECs) play in regulating smooth muscle cell (SMC) proliferation and in preventing thrombus formation, stent-induced endothelial damage is thought to be a significant contributor to stent-related complications. Thus, rapid endothelial wound healing is considered to be a critical factor in the success of a stenting procedure.…”
Section: Introductionmentioning
confidence: 99%
“…Evans blue could penetrate the areas where the endothelium is permeable and stain the injured surface blue. An intact endothelium could maintain an unstained surface[15]. The injured endothelium labeled by Evans blue could be observed in the 611 nm channel under a light-sheet microscopy.…”
mentioning
confidence: 99%